Roche
Tracked across 52 events · 1019 articles · First seen Apr 22, 2025 · Last active Aug 24, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Roche launched its new AXELIOS 1 sequencing platform, which is expected to enhance its position in the genomics market and potentially drive future revenue growth.
Jun 29, 2026 · 7 articles
Business
Impact: Roche is expanding its global technology network by establishing a new Digital Technology Hub in India — Hyderabad to leverage India's talent pool and strengthen its digital healthcare solutions. This expansion is expected to accelerate innovation and improve operational efficiency for the company.
Jul 01, 2026 · 7 articles
Tech
Impact: As a leading healthcare company, Roche>>> developed a rapid PCR test for the Bundibugyo virus through its subsidiary Trends (journals)>>>, significantly contributing to global outbreak response efforts and enhancing its reputation in diagnostics.
Jun 04, 2026 · 8 articles
Regulatory
Impact: Roche's supplemental Biologics License Application for Atezolizumab has been accepted by the United States — Food and Drug Administration>>> for Priority Review, potentially leading to a new standard of care for stage III colon cancer and boosting its market position.
Jun 11, 2026 · 6 articles
Regulatory
Impact: Roche received IVDR approval for its VENTANA MMR RxDx Panel, expanding its use across multiple cancer types and therapies, which is a positive development for the company's diagnostics division and market position.
Jun 11, 2026 · 6 articles
Business
Impact: Roche has entered into an exclusive licensing and collaboration agreement with Nurix Therapeutics to co-develop and co-commercialize bexobrutideg, strengthening its hematology portfolio and expanding into immunology and neurology. This deal positions Roche to potentially lead in the BTK degrader market.
Jun 07, 2026 · 22 articles
Business
Impact: Roche received CE Mark for its Elecsys IGRA TB test, expanding its diagnostics offering and potentially boosting sales in TB testing.
Jul 09, 2026 · 6 articles
Business
Impact: Roche introduced the cobas HDV test, expanding its diagnostics offering and reinforcing its leadership in automated molecular testing. The launch may drive incremental revenue and strengthen customer loyalty.
Jul 14, 2026 · 7 articles
Business
Impact: Roche is the main actor, launching new PCR tests to expand its cyclospora portfolio, reinforcing its position in infectious disease diagnostics and potentially boosting sales.
Aug 06, 2026 · 6 articles
Business
Impact: As a leading company in the CLIA market, Roche is strengthening its market position through innovation and strategic collaborations, with its cobas e series platforms playing a major role in advancing high-throughput immunodiagnostic testing globally.
Jun 05, 2026 · 6 articles
Business
Impact: Roche gains co-development and co-commercialization rights to bexobrutideg, a potential best-in-class BTK degrader, expanding its pipeline in oncology, immunology, and neurology.
Jul 21, 2026 · 6 articles
Tech
Impact: As the parent company of F. Hoffmann-La Roche — Genentech, Roche benefits from the positive clinical trial results of enicepatide and petrelintide, which enhance its overall pharmaceutical pipeline and potential for future revenue in the obesity and diabetes markets.
May 27, 2026 · 19 articles
Business
Impact: Roche is a key player in the antibody therapeutics market, benefiting from the projected market growth.
Jul 28, 2026 · 6 articles
Tech
Impact: Roche collaborates with Nurix on bexobrutideg development and co-commercialization in the US; the trial strengthens its oncology pipeline.
Aug 04, 2026 · 6 articles
Business
F. Hoffmann-La Roche — Genentech, a member of the Roche Group, held a topping out ceremony on August 18, 2026, marking the completion of the structural framework of its new biomanufacturing facility in United States…
Impact: Roche, as parent company, is investing in the facility as part of its $50 billion U.S. commitment, enhancing its manufacturing network and long-term growth prospects.
Aug 18, 2026 · 6 articles
Business
On August 24, 2026, Hanmi Pharm announced an exclusive licensing agreement with F. Hoffmann-La Roche — Genentech, a member of the Roche Group, for the worldwide development, manufacturing, and commercialization of HM17321, a novel UCN2…
Impact: As the parent of F. Hoffmann-La Roche — Genentech, Roche strengthens its cardiometabolic portfolio, aligning with its strategy to address obesity and related conditions.
Jul 20, 2026 · 7 articles
Tech
Impact: Roche Ltd. is recognized as a top company in the epigenetics market, indicating its significant role and potential to benefit from market expansion.
Jun 26, 2026 · 6 articles
Tech
Impact: As the parent company of F. Hoffmann-La Roche — Genentech>>>, Roche>>> benefits from the positive developments regarding giredestrant's regulatory progress and its potential market impact.
Jun 02, 2026 · 6 articles
Business
Multiple market research reports project significant growth in the global hematology analyzers and reagents market over the next several years. MarketsandMarkets forecasts growth from USD 7.57 billion in 2026 to USD 10.33 billion by 2031,…
Impact: Major diagnostics provider; growth forecasts favorable.
Jul 08, 2026 · 6 articles
International
Impact: Roche is expanding its output in North Carolina as part of the Swiss investment surge.
Jun 07, 2026 · 7 articles
Accidents
Impact: Roche is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Regulatory
Impact: Roche, parent of F. Hoffmann-La Roche — Genentech, stands to benefit from expanded use of Tecentriq in MIBC, potentially increasing drug sales.
Aug 05, 2026 · 7 articles
Business
Impact: Roche, as parent of F. Hoffmann-La Roche — Genentech, benefits indirectly from the partnership through F. Hoffmann-La Roche — Genentech's enhanced cell therapy development capabilities. The impact on Roche is modest.
Jul 21, 2026 · 6 articles
Domestic
Impact: Roche, among other pharmaceutical companies, had previously announced investments in U.S. production due to the threat of tariffs, but the new, higher tariffs introduce further uncertainty.
Sep 26, 2025 · 7 articles
Tech
Impact: Roche>>> developed Herceptin, one of the first antibody drugs used to treat HER2-positive breast cancer, as exemplified by Cathy Smithwick>>>'s treatment.
Jun 03, 2026 · 6 articles
Tech
Moderna and Merck & Co. announced on August 19, 2026, that their personalized mRNA cancer vaccine, Intismeran, combined with Merck's immunotherapy drug Pembrolizumab, met its primary and secondary goals in a Phase 3 trial for…
Impact: Roche is developing a similar personalized mRNA cancer vaccine, and the positive results validate the approach, potentially benefiting its pipeline.
Aug 19, 2026 · 102 articles
Business
Impact: Partnered with PathAI for AI-enabled companion diagnostics; key player in digital pathology.
Jun 24, 2026 · 8 articles
Business
Impact: Roche is a partner of Orano in developing targeted alpha therapies, suggesting potential for future collaboration and expansion in the oncology market.
Jul 01, 2026 · 9 articles
Business
Impact: Roche of Albertsons — Albertsons Media Collective commented on the practical application of the LAB program with Newton Research, highlighting the value of agentic data collaboration.
Jun 17, 2026 · 6 articles
Tech
Impact: Roche was an attendee at the summit, indicating its presence in the digital biomarkers space and potential interest in technologies like 'CART BP pro'.
Jul 03, 2026 · 8 articles
+ 22 more events
View on Dashboard
70
Roche invested $50 billion United StatesGenentech tops out Holly...
55
Roche testing similar treatmentModerna Merck mRNA...
+ 6 more relationships
View on Dashboard
ERGEN INTELLIGENCE
Track Roche live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard